NorthWest Biotherapeutics Inc (NWBO)

[Ready4bluesky]

Prior to the screening halt events, when you owned the stock, you held management's competence in very low regard. It doesn't sound like you consider the screening halt in and of itself to greatly increase the risk of failure, so what changed?

In the big picture, will the recent events have any impact on the eventual SP we will see with unfavorable trial results? What about the SP we will see with AA designation? How does the screening halt factor into either of those scenarios?